Ignite Creation Date:
2024-05-05 @ 11:30 AM
Last Modification Date:
2024-10-26 @ 9:08 AM
Study NCT ID:
NCT00060112
Status:
TERMINATED
Last Update Posted:
2013-01-25
First Post:
2003-05-06
Brief Title:
Oblimersen and Gemcitabine in Treating Patients With Advanced Solid Tumor or Lymphoma
Sponsor:
National Cancer Institute NCI
Organization:
National Cancer Institute NCI
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Unspecified Adult Solid Tumor Protocol Specific |
| Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue |
| Nodal Marginal Zone B-cell Lymphoma |
| Recurrent Adult Burkitt Lymphoma |
| Recurrent Adult Diffuse Large Cell Lymphoma |
| Recurrent Adult Diffuse Mixed Cell Lymphoma |
| Recurrent Adult Diffuse Small Cleaved Cell Lymphoma |
| Recurrent Adult Hodgkin Lymphoma |
| Recurrent Adult Immunoblastic Large Cell Lymphoma |
| Recurrent Adult Lymphoblastic Lymphoma |
| Recurrent Adult T-cell LeukemiaLymphoma |
| Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma |
| Recurrent Grade 1 Follicular Lymphoma |
| Recurrent Grade 2 Follicular Lymphoma |
| Recurrent Grade 3 Follicular Lymphoma |
| Recurrent Mantle Cell Lymphoma |
| Recurrent Marginal Zone Lymphoma |
| Recurrent Small Lymphocytic Lymphoma |
| Splenic Marginal Zone Lymphoma |
| Stage IV Adult Burkitt Lymphoma |
| Stage IV Adult Diffuse Large Cell Lymphoma |
| Stage IV Adult Diffuse Mixed Cell Lymphoma |
| Stage IV Adult Diffuse Small Cleaved Cell Lymphoma |
| Stage IV Adult Hodgkin Lymphoma |
| Stage IV Adult Immunoblastic Large Cell Lymphoma |
| Stage IV Adult Lymphoblastic Lymphoma |
| Stage IV Adult T-cell LeukemiaLymphoma |
| Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma |
| Stage IV Grade 1 Follicular Lymphoma |
| Stage IV Grade 2 Follicular Lymphoma |
| Stage IV Grade 3 Follicular Lymphoma |
| Stage IV Mantle Cell Lymphoma |
| Stage IV Marginal Zone Lymphoma |
| Stage IV Small Lymphocytic Lymphoma |
Keywords: